世界の迅速検査市場2022-2029:製品別(器具、消耗品、その他)、技術別、用途別、エンドユーザー別、地域別

【英語タイトル】Global Rapid Tests Market Size study & Forecast, by Product (Instruments, Consumables, Others), by Technology ( Molecular Diagnostics, Immunoassay and Others) by Application (Upper Respiratory Tract Infections, Antibiotic, Sepsis), by End Use (Hospitals & Clinics, Laboratories and At - Home Testing and Others) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW23MA046)・商品コード:BZW23MA046
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2023年4月10日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:実験機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社の本調査資料では、2021年に11.9億ドルであった世界の迅速検査市場規模が、2022年〜2029年にかけて年平均8.6%で成長すると予測しています。本資料は、迅速検査の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、製品別(器具、消耗品、その他)分析、技術別(分子生物学的診断法 、イムノアッセイ、その他)分析、用途別(上気道感染症、抗生物質、敗血症)分析、エンドユーザー別(病院・診療所、研究室、家庭用試験、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、Abbott、BD (Becton, Dickinson and Company)、bioMérieux SA、DiaSorin S.p.A.、Danaher Corporation、Thermo Fisher Scientific, Inc.、F. Hoffmann - La Roche Ltd、Meridian Bioscience, Inc.、Bio-rad Laboratories, Inc.などの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の迅速検査市場規模:製品別
- 器具の市場規模
- 消耗品の市場規模
- その他製品の市場規模
・世界の迅速検査市場規模:技術別
- 分子生物学的診断法における市場規模
- イムノアッセイにおける市場規模
- その他技術における市場規模
・世界の迅速検査市場規模:用途別
- 上気道感染症における市場規模
- 抗生物質における市場規模
- 敗血症における市場規模
・世界の迅速検査市場規模:エンドユーザー別
- 病院・診療所における市場規模
- 研究室における市場規模
- 家庭用試験における市場規模
- その他エンドユーザーにおける市場規模
・世界の迅速検査市場規模:地域別
- 北米の迅速検査市場規模
- ヨーロッパの迅速検査市場規模
- アジア太平洋の迅速検査市場規模
- 中南米の迅速検査市場規模
- その他地域の迅速検査市場規模
・競争分析
・調査プロセス

Global Rapid Tests Market is valued approximately USD 1.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2022-2029 Rapid tests, commonly referred to as RDTs or rapid diagnostic tests, are simple to use procedures that offer prompt answers, typically in few minutes or less. Rapid tests are performed and give results at the point of treatment, unlike the majority of regular tests, which must be forwarded to a lab. The Rapid Tests market is expanding because of factors such as increasing adoption of Self – Testing & Point – Of – Care Products, and introduction Of CLIA Waived Test and growing Geriatric Population Base. However, the presence of ambiguous regulatory may halt market growth.

Diabetes is one of the world’s fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades. The primary factors propelling market expansion are the rising elderly population, increasing target disease burden, and increased usage of self-testing & point-of-care products. According to the World Health Organization, diabetes will afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Additionally, the market is expanding as a result of the introduction of technologically advanced items. However, the main difficulty with quick diagnostics solutions is quality assurance, which is expected to limit market expansion.

The key regions considered for the Global Rapid Tests Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the emergence of technologically advanced products, high rates of infections with upper respiratory diseases and antibiotic resistance, and high healthcare costs Additionally, the usage of PoC & fast diagnostics for the diagnosis of numerous ailments in the region, as well as encouraging government initiatives, are supporting the market’s expansion. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Abbott
BD (Becton, Dickinson and Company)
bioMérieux SA
DiaSorin S.p.A.
Danaher Corporation
Thermo Fisher Scientific, Inc.
F. Hoffmann – La Roche Ltd
Meridian Bioscience, Inc.
Bio-rad Laboratories, Inc.

Recent Developments in the Market:
 In August 2022, Accelerate Diagnostics and BD collaborated commercially. Through this strategic strategy, BD would provide Accelerate Diagnostics’ quick diagnostics for antibiotic resistance and susceptibility over the world.
 In December 2022, Roche stated that the U.S. Food and Drug Administration had authorised the COVID-19 At-home Test for Emergency Use. The test involves a straightforward anterior nasal swab sample that may be easily obtained and self-tested by those age 14 and older. For children aged 2 to 13, an adult must administer the test.

Global Rapid Tests Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Technology, Application, , End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Instruments
Consumables
Others

By Technology:
Molecular Diagnostics
Immunoassay
Others

By Application:
Upper Respiratory Tract Infections
Antibiotic
Sepsis

By End Use:
Hospitals & Clinics
Laboratories
At – Home Testing
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Rapid Tests Market, by Region, 2019-2029 (USD Billion)
1.2.2. Rapid Tests Market, by Product, 2019-2029 (USD Billion)
1.2.3. Rapid Tests Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Rapid Tests Market, by Application, 2019-2029 (USD Billion)
1.2.5. Rapid Tests Market, by End Use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Rapid Tests Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Rapid Tests Market Dynamics
3.1. Rapid Tests Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing Adoption Of Self – Testing & Point – Of – Care Products, And Introduction Of CLIA Waived Tests
3.1.1.2. Growing Geriatric Population Base
3.1.2. Market Challenges
3.1.2.1. Presence Of Ambiguous Regulatory
3.1.2.2. Reimbursement Framework For Primary Care Setting
3.1.3. Market Opportunities
3.1.3.1. Introduction Of Advance Technology Enabled Products
3.1.3.2. Growing Prevalence Of Target Diseases
Chapter 4. Global Rapid Tests Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Rapid Tests Market, by Product
6.1. Market Snapshot
6.2. Global Rapid Tests Market by Product, Performance – Potential Analysis
6.3. Global Rapid Tests Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Rapid Tests Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Consumables
6.4.3. Others
Chapter 7. Global Rapid Tests Market, by Technology
7.1. Market Snapshot
7.2. Global Rapid Tests Market by Technology, Performance – Potential Analysis
7.3. Global Rapid Tests Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
7.4. Rapid Tests Market, Sub Segment Analysis
7.4.1. Molecular Diagnostics
7.4.2. Immunoassay
7.4.3. Others
Chapter 8. Global Rapid Tests Market, by Application
8.1. Market Snapshot
8.2. Global Rapid Tests Market by Application, Performance – Potential Analysis
8.3. Global Rapid Tests Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Rapid Tests Market, Sub Segment Analysis
8.4.1. Upper Respiratory Tract Infections
8.4.2. Antibiotic
8.4.3. Sepsis
Chapter 9. Global Rapid Tests Market, by End Use
9.1. Market Snapshot
9.2. Global Rapid Tests Market by End Use, Performance – Potential Analysis
9.3. Global Rapid Tests Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
9.4. Rapid Tests Market, Sub Segment Analysis
9.4.1. Hospitals & Clinics
9.4.2. Laboratories
9.4.3. At – Home Testing
9.4.4. Others
Chapter 10. Global Rapid Tests Market, Regional Analysis
10.1. Rapid Tests Market, Regional Market Snapshot
10.2. North America Rapid Tests Market
10.2.1. U.S. Rapid Tests Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Rapid Tests Market
10.3. Europe Rapid Tests Market Snapshot
10.3.1. U.K. Rapid Tests Market
10.3.2. Germany Rapid Tests Market
10.3.3. France Rapid Tests Market
10.3.4. Spain Rapid Tests Market
10.3.5. Italy Rapid Tests Market
10.3.6. Rest of Europe Rapid Tests Market
10.4. Asia-Pacific Rapid Tests Market Snapshot
10.4.1. China Rapid Tests Market
10.4.2. India Rapid Tests Market
10.4.3. Japan Rapid Tests Market
10.4.4. Australia Rapid Tests Market
10.4.5. South Korea Rapid Tests Market
10.4.6. Rest of Asia Pacific Rapid Tests Market
10.5. Latin America Rapid Tests Market Snapshot
10.5.1. Brazil Rapid Tests Market
10.5.2. Mexico Rapid Tests Market
10.5.3. Rest of Latin America Rapid Tests Market
10.6. Rest of The World Rapid Tests Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Abbott
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. BD (Becton, Dickinson and Company)
11.2.3. bioMérieux SA
11.2.4. DiaSorin S.p.A.
11.2.5. Danaher Corporation
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. F. Hoffmann – La Roche Ltd
11.2.8. Meridian Bioscience, Inc.
11.2.9. Bio-rad Laboratories, Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption



★調査レポート[世界の迅速検査市場2022-2029:製品別(器具、消耗品、その他)、技術別、用途別、エンドユーザー別、地域別] (コード:BZW23MA046)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の迅速検査市場2022-2029:製品別(器具、消耗品、その他)、技術別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆